Evercore ISI Group Downgrades Roku to In-Line, Announces $75 Price Target
Evercore ISI Group analyst Shweta Khajuria downgrades Roku (NASDAQ:ROKU) from Outperform to In-Line and announces $75 price target.
DZ Bank Downgrades Qualcomm to Hold, Announces $150 Price Target
DZ Bank analyst Ingo Wermann downgrades Qualcomm (NASDAQ:QCOM) from Buy to Hold and announces $150 price target.
DZ Bank Downgrades Meta Platforms to Sell, Announces $140 Price Target
DZ Bank analyst Ingo Wermann downgrades Meta Platforms (NASDAQ:META) from Hold to Sell and announces $140 price target.
Baird Downgrades Intel to Neutral, Lowers Price Target to $40
Baird analyst Tristan Gerra downgrades Intel (NASDAQ:INTC) from Outperform to Neutral and lowers the price target from $60 to $40.
RBC Capital Downgrades Bausch Health Companies to Sector Perform, Lowers Price Target to $5
RBC Capital analyst Douglas Miehm downgrades Bausch Health Companies (NYSE:BHC) from Outperform to Sector Perform and lowers the price target from $12 to $5.
Canaccord Genuity Downgrades Edwards Lifesciences to Hold, Lowers Price Target to $106
Canaccord Genuity analyst William Plovanic downgrades Edwards Lifesciences (NYSE:EW) from Buy to Hold and lowers the price target from $115 to $106.
Needham Downgrades Verano Holdings to Hold
Needham analyst Matt McGinley downgrades Verano Holdings (OTC:VRNOF) from Buy to Hold.
Baird Downgrades argenx to Neutral, Raises Price Target to $460
Baird analyst Joel Beatty downgrades argenx (NASDAQ:ARGX) from Outperform to Neutral and raises the price target from $374 to $460.
JP Morgan Downgrades Bausch Health Companies to Neutral
JP Morgan analyst Chris Schott downgrades Bausch Health Companies (NYSE:BHC) from Overweight to Neutral.
JP Morgan Downgrades Holley to Neutral, Lowers Price Target to $9
JP Morgan analyst Christian Carlino downgrades Holley (NYSE:HLLY) from Overweight to Neutral and lowers the price target from $14 to $9.